Jonathan Gortat of Stanford's Office of Technology Licensing: The Hard Part of Innovation Is Not the Invention

At Taiwan Tech Day: From Lab to Market, Jonathan Gortat’s keynote brought the audience into one of the most important but least understood parts of the innovation economy: the licensing deal. Jonathan is the Director for Licensing and Strategic Alliances at Stanford University’s Office of Technology Licensing.

When people talk about breakthrough technology, they often focus on the discovery. A new material. A new medical platform. A new AI model. A new sensor. A new semiconductor process. The story usually begins with the lab and then jumps quickly to the market, as if the path from invention to product is a straight line.

Gortat’s talk reminds us that the space between the lab and the market is not a hallway. It is a negotiation table.

That table is where invention becomes strategy. It is where scientific promise is translated into commercial rights, business obligations, investor confidence, startup formation, corporate partnerships, timelines, responsibilities, and long term value. A licensing deal is not just a legal document. It is the operating system that determines whether a technology has a real chance to become a product. This is why technology transfer is so complex. The university or research institution wants the invention to reach the public. The inventor wants to see the work succeed and create impact. The startup or corporate partner wants enough rights to justify investment. Investors want clarity, defensibility, and upside. The market wants something useful, affordable, reliable, and scalable.

All of these interests overlap, but they are not identical.

That is the heart of Gortat’s message. A high impact licensing deal is not built by simply assigning a patent to a company. It must balance risk, incentives, control, access, timing, and trust. One of the most important ideas in his speech is that licensing is not only about ownership. It is about alignment. Who has the right to use the technology? In what field? In what geography? For how long? Under what performance expectations? What happens if the licensee does not commercialize the technology? What happens if the market changes? What happens if the original use case turns out to be less promising than a different one?

These questions matter because early decisions can shape the entire life of a technology.

For example, an exclusive license may help a startup raise money because investors want to know that the company controls its core intellectual property. But too much exclusivity can also limit the broader impact of a technology if one company is unable to develop every possible market. A nonexclusive license may spread a technology more widely, but it may not give a single partner enough confidence to invest heavily in commercialization.

There is no perfect answer. The right structure depends on the technology, the market, the business model, the development timeline, and the type of partner involved.

This is especially important in deep tech. Unlike many software products, deep tech inventions often require years of development before they reach full commercial readiness. They may need regulatory approval, manufacturing scale up, clinical validation, hardware integration, capital equipment, safety testing, or supply chain partners. The licensing agreement has to account for that reality.

A weak deal can kill momentum. A rigid deal can trap a technology. A vague deal can scare away investors. A deal that is too one sided can create conflict later. But a thoughtful deal can give all parties enough confidence to move forward.

That is why Gortat’s perspective is valuable. Technology transfer sits at the intersection of science, law, business, investment, and public benefit. It requires people who understand both the promise of the invention and the practical reality of commercialization.

His talk also highlights a larger lesson for Taiwan’s innovation ecosystem.

Taiwan has world class engineering talent, industrial depth, manufacturing capability, and research strength. But in the AI era, the challenge is not only to create technology. The challenge is to commercialize it globally. That requires strong intellectual property strategy, market selection, venture readiness, corporate partnerships, and licensing structures that help technology travel across borders.

For Taiwan and Silicon Valley, this is where the conversation becomes especially powerful.

Taiwan knows how to build. Silicon Valley knows how to scale companies, finance risk, and connect products to global markets. Stanford’s technology transfer experience adds another important layer: how to move inventions from academic and research environments into companies that can carry them forward.

The combination is not just symbolic. It is practical.

A Taiwanese research team may have a promising technology, but it needs a clear commercialization pathway. A Silicon Valley startup may understand market opportunity, but it needs strong technical foundations. A corporate partner may want access to innovation, but it needs clarity on rights and obligations. An investor may be interested, but only if the deal structure supports growth.

Licensing is where these pieces come together.

Gortat’s speech also challenges a common misconception about innovation. Many people assume that the main obstacle is technical feasibility. Can the technology work? Can the prototype perform? Can the science be validated?

Those questions are essential, but they are not enough. A technology can work and still fail to reach the market. It can be brilliant and still be commercially stranded. It can be patented and still never become a product.

The final mile of innovation is often not scientific. It is institutional. It is relational. It is strategic.

Who will carry the technology forward? Who will fund the next stage? Who has the right to make decisions? Who takes on the risk? Who receives the reward? Who protects the public mission? Who makes sure the technology does not sit unused?

These are not small details. They are the architecture of impact.

That is why the phrase “from lab to market” should not be treated as a slogan. It is a discipline. It requires patience, judgment, and structure. It requires institutions that know how to evaluate technologies, protect intellectual property, find the right partners, and design agreements that can survive uncertainty.

In the AI era, this becomes even more urgent. AI is moving beyond software into healthcare, robotics, manufacturing, logistics, defense, energy, and the physical world. These are areas where commercialization is complex and the stakes are high. The technologies may involve multiple layers of intellectual property, data, hardware, software, safety concerns, and regulatory obligations.

A poorly structured deal in this environment can slow down innovation. A well structured deal can accelerate it.

Gortat’s talk is worth watching because it gives viewers a clearer understanding of what actually happens behind the scenes when research becomes a company, a product, or a platform. It shows that technology transfer is not a clerical process. It is a strategic function that can determine whether an invention becomes a real world solution.

For founders, the talk is a reminder to think early about intellectual property, licensing terms, market rights, and investor expectations.

For researchers, it is a reminder that publication and invention are only part of the journey. Commercialization requires partners who can develop, fund, and deploy the technology.

For investors, it is a reminder that the quality of a licensing deal can directly affect the quality of the investment opportunity.

For government and ecosystem leaders, it is a reminder that supporting innovation means building the legal, financial, and institutional bridges that help research become impact.

And for anyone interested in Taiwan’s role in the next generation of deep tech, the talk offers an important perspective. Taiwan’s technical strength is already clear. The next opportunity is to pair that strength with stronger commercialization pathways, better cross border partnerships, and licensing structures that help technology move faster into global markets.

The real lesson of Gortat’s keynote is this: invention starts the story, but licensing can decide whether the story reaches the world.

Watch the speech to better understand the hidden architecture behind technology commercialization, and why the future of deep tech depends not only on what we invent, but on how intelligently we move those inventions from the lab into the market.